References
- Farnik H , BojungaJ, BergerAet al. Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patients. Hepatology58(4), 1270–1276 (2013).
- Rosen CJ . Clinical practice. Vitamin D insufficiency. N. Engl. J. Med.364(3), 248–254 (2011).
- Campbell FC , XuH, El-TananiM, CroweP, BinghamV. The yin and yang of vitamin D receptor (VDR) signaling in neoplastic progression: operational networks and tissue-specific growth control. Biochem. Pharmacol.79(1), 1–9 (2010).
- Hargrove L , FrancisT, FrancisH. Vitamin D and GI cancers: shedding some light on dark diseases. Ann. Transl. Med.2(1), 9 (2014).
- Kitson MT , SarrazinC, ToniuttoP, EslickGD, RobertsSK. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis. J. Hepatol.61(6), 1247–1252 (2014).
- Kennedy L , BakerK, HodgesKet al. Dysregulation of vitamin D3 synthesis leads to enhanced cholangiocarcinoma growth. Dig. Liver Dis.45(4), 316–322 (2013).
- Horvath E , LakatosP, BallaBet al. Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration. Anticancer Res.32(11), 4791–4796 (2012).
- Hammad LN , AbdelraoufSM, HassaneinFS, MohamedWA, SchaalanMF. Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: potential biomarkers for a more favorable prognosis?J. Immunotoxicol.10(4), 380–386 (2013).
- Pourgholami MH , AkhterJ, LuY, MorrisDL. In vitro and in vivo inhibition of liver cancer cells by 1,25-dihydroxyvitamin D3. Cancer Lett.151(1), 97–102 (2000).
- Akhter J , LuY, FinlayI, PourgholamiMH, MorrisDL. 1alpha,25-Dihydroxyvitamin D3 and its analogues, EB1089 and CB1093, profoundly inhibit the in vitro proliferation of the human hepatoblastoma cell line HepG2. ANZ J. Surg.71(7), 414–417 (2001).
- Chandel N , MalhotraA, SinghalPC. Vitamin D receptor and epigenetics in HIV infection and drug abuse. Front. Microbiol.6, 788 (2015).
- Conesa-Botella A , MeintjesG, CoussensAKet al. Corticosteroid therapy, vitamin D status, and inflammatory cytokine profile in the HIV-tuberculosis immune reconstitution inflammatory syndrome. Clin. Infect. Dis.55(7), 1004–1011 (2012).
- Wu H , LiN, JinRet al. Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation. Sci. Rep.6, 18528 (2016).
- Lange CM , GouttenoireJ, DuongFH, MorikawaK, HeimMH, MoradpourD. Vitamin D receptor and Jak-STAT signaling crosstalk results in calcitriol-mediated increase of hepatocellular response to IFN-alpha. J. Immunol.192(12), 6037–6044 (2014).
- Coussens AK , WilkinsonRJ, HanifaYet al. Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment. Proc. Natl Acad. Sci. USA109(38), 15449–15454 (2012).
- Lu X , LiZ, LiQet al. Preferential loss of gut-homing α4β7 CD4 T cells and their circulating functional subsets in acute HIV-1 infection. Cell. Mol. Immunol.13(6), 776–784 (2016).
- SNP database . http://www.ncbi.nlm.nih.gov/SNP.
- HapMap . www.hapmap.org.
- Wang W , LiW, YangXet al. Interleukin-8 is elevated in severe hand, foot, and mouth disease. J. Infect. Dev. Countries8(1), 94–100 (2014).
- Wang W , ZhuY, WuH, JiaoY, Van Halm-LutterodtN, LiW. IL-6 and IFN gamma are elevated in severe mumps cases: a study of 960 mumps patients in China. J. Infect. Dev. Countries8(2), 208–214 (2014).
- Li W , HendersonLJ, MajorEO, Al-HarthiL. IFN-gamma mediates enhancement of HIV replication in astrocytes by inducing an antagonist of the beta-catenin pathway (DKK1) in a STAT 3-dependent manner. J. Immunol.186(12), 6771–6778 (2011).
- Li W , Lewis-AntesA, HuangJ, BalanM, KotenkoSV. Regulation of apoptosis by type III interferons. Cell Prolif.41(6), 960–979 (2008).
- Cohen MS , ShawGM, McMichaelAJ, HaynesBF. Acute HIV-1 infection. N. Engl. J. Med.364(20), 1943–1954 (2011).
- Mansueto P , SeiditaA, VitaleG, GangemiS, IariaC, CascioA. Vitamin D deficiency in HIV infection: not only a bone disorder. BioMed Res. Int.2015, 735615 (2015).
- Hidron AI , HillB, GuestJL, RimlandD. Risk factors for vitamin D deficiency among veterans with and without HIV infection. PLoS ONE10(4), e0124168 (2015).
- Moodley A , QinM, SinghKK, SpectorSA. Vitamin D-related host genetic variants alter HIV disease progression in children. Pediatr. Infect. Dis. J.32(11), 1230–1236 (2013).
- Torres C , Sanchez de la TorreM, Garcia-MorujaCet al. Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression. Curr. HIV Res.8(6), 487–492 (2010).
- Peng Q , YangS, LaoXet al. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population. PLoS ONE9(12), e116026 (2014).
- Yao X , ZengH, ZhangGet al. The associated ion between the VDR gene polymorphisms and susceptibility to hepatocellular carcinoma and the clinicopathological features in subjects infected with HBV. BioMed Res. Int.2013, 953974 (2013).
- Falleti E , BitettoD, FabrisCet al. Vitamin D receptor gene polymorphisms and hepatocellular carcinoma in alcoholic cirrhosis. World J. Gastroenterol.16(24), 3016–3024 (2010).
- Wack A , Terczynska-DylaE, HartmannR. Guarding the frontiers: the biology of type III interferons. Nat. Immunol.16(8), 802–809 (2015).
- Stiff A , Carson IiiW. Investigations of interferon-lambda for the treatment of cancer. J. Innate Immun.7(3), 243–250 (2015).